121 related articles for article (PubMed ID: 1827004)
1. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
Am J Hypertens; 1991 Feb; 4(2 Pt 2):135S-139S. PubMed ID: 1827004
[TBL] [Abstract][Full Text] [Related]
2. Isradipine: overall clinical experience in hypertension in the United States.
Miller H
J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S60-4. PubMed ID: 1695305
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of isradipine in hypertension.
Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
[TBL] [Abstract][Full Text] [Related]
4. Improved blood pressure control with isradipine in hypertensive patients treated with pindolol.
Frithz G; Aström B; Dahlöf B; Hansson L; Tollin C; Himanen P; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):115-8. PubMed ID: 2523645
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive activity of isradipine in humans: a new dihydropyridine calcium channel antagonist.
Nelson EB; Pool JL; Taylor AA
Clin Pharmacol Ther; 1986 Dec; 40(6):694-7. PubMed ID: 2946507
[TBL] [Abstract][Full Text] [Related]
6. A multicenter comparison of the safety and efficacy of isradipine and enalapril in the treatment of hypertension.
Eisner GM; Johnson BF; McMahon FG; Rudd P; Sowers JR; Vargas R; Zemel M
Am J Hypertens; 1991 Feb; 4(2 Pt 2):154S-157S. PubMed ID: 1827008
[TBL] [Abstract][Full Text] [Related]
7. Isradipine vs propranolol in hydrochlorothiazide-treated hypertensives. A multicenter evaluation.
Prisant LM; Carr AA; Nelson EB; Winer N; Velasquez MT; Gonasun LM
Arch Intern Med; 1989 Nov; 149(11):2453-7. PubMed ID: 2530945
[TBL] [Abstract][Full Text] [Related]
8. An acute dose-response pharmacodynamic evaluation of orally administered isradipine (PN-200-110) in hypertensive patients.
McMahon FG; Vargas R; Ryan JR; Miller H; Faraday S
J Clin Pharmacol; 1988 Jul; 28(7):664-6. PubMed ID: 2975291
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of isradipine (PN 200-110) in mild to moderate hypertension.
Winer N; Thys-Jacobs S; Kumar R; Davidson WD; Grayson M; Harris C; Walker D; Itskovitz H; Gonasun L
Clin Pharmacol Ther; 1987 Oct; 42(4):442-8. PubMed ID: 2959426
[TBL] [Abstract][Full Text] [Related]
10. Multicentre isradipine dose-confirmation study in Thai patients with hypertension.
Tanomsup S; Tantbirojn P; Koanantakul B; Nontakanun S; Jaroonvesama N; Charoenlarp K
Drugs; 1990; 40 Suppl 2():22-5. PubMed ID: 2150635
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparison of once- and twice-daily isradipine to hydrochlorothiazide for the treatment of hypertension in elderly patients.
Holtzman JL; Abrams A; Cutler R; Hamilton B; Kirkendall WM; Neri G; Stein GH; Matthews KP
Clin Pharmacol Ther; 1990 Nov; 48(5):590-7. PubMed ID: 2146060
[TBL] [Abstract][Full Text] [Related]
12. Isradipine dose-confirmation study in Filipino patients with mild to moderate hypertension.
Abarquez RF; Cabral EI; Namin EP; Calleja HB; Porciuncula CI; Divinagracia RA; Anastacio RV; Castillo RR
Drugs; 1990; 40 Suppl 2():33-7. PubMed ID: 2150639
[TBL] [Abstract][Full Text] [Related]
13. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
Simonsen K; Sundstedt CD
Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the safety and efficacy of isradipine in elderly patients with essential hypertension. The British Isradipine Hypertension Group.
Am J Med; 1989 Apr; 86(4A):110-4. PubMed ID: 2523644
[TBL] [Abstract][Full Text] [Related]
15. Isradipine twice daily lowers blood pressure over 24 H.
Man in't Veld AJ; Holmes DG; Lasance A; de Zwart P
Am J Hypertens; 1991 Feb; 4(2 Pt 2):131S-134S. PubMed ID: 1827003
[TBL] [Abstract][Full Text] [Related]
16. Additive effect of isradipine in combination with captopril in hypertensive patients.
Eggertsen R; Svensson A; Dahlöf B; Hansson L
Am J Med; 1989 Apr; 86(4A):124-6. PubMed ID: 2523647
[TBL] [Abstract][Full Text] [Related]
17. Twenty-four-hour blood pressure control with isradipine in mild essential hypertension.
Viskoper JR; Laszt A; Faraggi D
Am J Hypertens; 1991 Feb; 4(2 Pt 2):161S-162S. PubMed ID: 1827010
[TBL] [Abstract][Full Text] [Related]
18. The calcium antagonist isradipine in the therapy of hypertension. A double-blind crossover comparison with nifedipine.
Welzel D; Burger KJ
Drugs; 1990; 40 Suppl 2():60-4. PubMed ID: 2150644
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effects of isradipine and captopril as monotherapy or in combination.
Fitscha P; Meisner W; Hitzenberger G
Am J Hypertens; 1991 Feb; 4(2 Pt 2):151S-153S. PubMed ID: 1827007
[TBL] [Abstract][Full Text] [Related]
20. Multicenter evaluation of efficacy, tolerability and safety of a new first-line antihypertensive drug, isradipine, in a Latin-American population.
Gómez G; Melgarejo E; Narváez J; Gamarra G; Restrepo G; Acevedo L; Izurieta A
Am J Hypertens; 1991 Feb; 4(2 Pt 2):128S-130S. PubMed ID: 1827002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
